Latest — CapitSignal

Sagility Ltd.SAGILITY21:25ImprovingNotable

Sagility acquires Chirok Health to expand provider-focused services

M&Aacquisition

As filed

SAGILITY LIMITED has informed the Exchange regarding a press release dated October 21, 2026, titled "Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health".

Why it matters

CapitSignal interpretation

The transaction broadens Sagility’s provider-focused offering into specialized clinical documentation, coding, revenue integrity, and value-based care support. Sagility expects the combination to create opportunities to expand services across both companies’ client bases.

What happened

Fact

Sagility acquired Chirok Health, which provides clinical documentation improvement, medical coding, coding audit and quality assurance, and revenue integrity services. Sagility said the acquisition expands its provider-services capabilities and complements its existing revenue cycle management, patient access, analytics, and technology and AI-led operations.

Watch next

Fact

Financial terms and expected financial contribution of the acquisition
Integration of Chirok Health’s clinical and coding capabilities
Expansion of services across the combined client base

Full analysis Company memory

Sagility Ltd.SAGILITY21:20ImprovingNotable

Sagility to acquire Chirok Health for up to US$32.35 million

M&Aacquisition

As filed

SAGILITY LIMITED has informed the Exchange about Sagility Accelerates Provider Growth Strategy Through Acquisition of Chirok Health

Why it matters

CapitSignal interpretation

The acquisition adds Clinical Documentation Integrity, medical coding and revenue-optimisation capabilities to Sagility's provider-segment healthcare services portfolio. The performance-linked portion of the consideration ties part of the deal value to specified milestones.

What happened

Fact

Sagility (US) Holdings Inc., a wholly owned subsidiary of Sagility Limited, signed a definitive agreement to acquire 100% of Chirok Health LLC. The cash deal comprises US$20.0 million upfront at closing, subject to customary closing adjustments, and up to US$12.35 million in contingent consideration tied to performance milestones.

US$ 32.35 MMaximum purchase consideration
aggregate cash purchase consideration
US$ 20.0 MUpfront payment
payment at closing, subject to customary closing adjustments
upto US$ 12.35 MContingent consideration
payable on achievement of specified performance milestones
100%Stake acquired
shareholding/control acquired in Chirok Health LLC
US$ 9.0 MChirok CY2025 turnover
target entity turnover
USD 8.2 MChirok CY2024 turnover
target entity turnover
USD 12.7 MChirok CY2023 turnover
target entity turnover

Watch next

Fact

Completion of the acquisition, indicated for 21st October 2026
Achievement of performance milestones governing up to US$ 12.35 M of contingent consideration
Integration of Chirok's CDI, coding and CHEMP workflow-platform capabilities

Full analysis Company memory

Eternal Ltd.ETERNAL15:33MixedMinor

Eternal approves Going-out business consolidation and Mygate share-swap deal

M&Adivestment

As filed

Eternal Limited has informed exchange regarding proposed restructuring, acquisition and divestment.

Why it matters

CapitSignal interpretation

The internal transfer places the Going-out India operations, which contributed 5.39% of standalone FY 2025-26 revenue, under one wholly owned subsidiary. The Adonmo-for-Mygate transaction would convert Eternal's Adonmo investment into an expected ~4.4% fully diluted stake in the merged Mygate entity, subject to definitive agreements and closing conditions.

What happened

Fact

The board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. It also approved transferring the Going-out India business to wholly owned subsidiary ZEPL through a slump sale, while approving a transaction to exchange its entire Adonmo holding for Mygate shares ahead of the proposed Adonmo-Mygate merger.

INR 587 croreGoing-out India business revenue
FY 2025-26 revenue of the identified business
5.39%Revenue contribution
share of Eternal standalone revenue in FY 2025-26
~ 4.4%Expected stake in merged Mygate entity
fully diluted equity stake after the proposed merger
INR 156 croreCurrent value of expected Mygate stake
value stated for the eventual stake in the merged Mygate entity
INR 112 croreAdonmo investment
amount invested by the company in January 2022

Watch next

Fact

Execution of the Business Transfer Agreement and consolidation of Going-out India operations from OTPL and WEPL into ZEPL.
Execution of definitive agreements and satisfaction of closing conditions for the Adonmo-Mygate transaction.
Completion of the proposed Adonmo-Mygate merger and Eternal's resulting fully diluted stake.

Full analysis Company memory

Thursday, 22 October 2026

Why it matters

What happened

Live special situations

Thursday, 22 October 2026

Why it matters

What happened

Live special situations

Wednesday, 21 October 2026

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Monday, 19 October 2026

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next